MétaCan
Menu
← Back to cohort
Record W4407636209 · doi:10.1136/bmjopen-2024-085255

Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trial

2025· article· en· W4407636209 on OpenAlexafffundabout
Intissar Souli, Julie Lapointe, Jura Kinsley-Marlie, Jocelyne Chiquette, Michel Dorval, Caroline Diorio, Sophie Lauzier, Étienne Audet‐Walsh, Steve Bilodeau, Madeleine Côté, Carmen Brisson, Nelson Charette, Pierre‐Hugues Fortier, Jean‐Sébastien Paquette, Yves Fradet, Josée Savard, Vincent Fradet, Hermann Nabi

Bibliographic record

VenueBMJ Open · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsCentre hospitalier universitaire de QuébecCegep regional de LanaudiereCentre Intégré de Santé et de Services Sociaux du Bas-Saint-LaurentUniversité LavalCentre hospitalier de l'Université Laval
FundersCanadian Cancer SocietyCanadian Institutes of Health ResearchFondation du cancer du sein du Québec
KeywordsMedicineCancer preventionThematic analysisDescriptive statisticsRandomized controlled trialBreast cancerFamily medicineGynecologyCancerQualitative researchInternal medicine

Abstract

fetched live from OpenAlex

Introduction Several primary prevention strategies, including chemoprevention, prophylactic surgery and lifestyle modifications, have been shown to reduce the risk of breast cancer (BC) and prostate cancer (Pca). However, the uptake of these preventive measures is considered suboptimal, limiting their impact on cancer prevention. A personalised primary prevention strategy has yet to be tested for cancer prevention. Therefore, we aim to determine the feasibility, acceptability and potential benefits and harms of this strategy in women and men at high risk of BC and Pca. Methods and analysis This is a two-arm, parallel-group mixed-methods pilot randomised controlled trial with a 1:1 allocation. The study aims to recruit 60 women and 60 men at high risk of BC and PCa in two specialised sites: the Breast Diseases Center and the Department of Urologic Oncology of the CHU de Québec-Université Laval, Canada. Assessments include intentions to uptake, actual uptake rates of primary preventive measures and decision regret. Feasibility and acceptability of the intervention and the study will be measured by quantifying the recruitment rate, appropriateness of randomisation process and satisfaction metrics. Data will be collected using mixed methods. Quantitative measures will be assessed at baseline and 6 months post randomisation. Quantitative analysis will include descriptive statistics for all variables of interest. Generalised linear mixed models with random intercepts will be used to assess the overall intervention effect. Semistructured interviews will be conducted at the end of follow-up, and a thematic analysis will be performed using NVivo to understand participants’ perspectives. Ethics and dissemination The protocol was approved by the Institutional Review Board of CHU de Québec-Université Laval (4 October 2022; 2023-6315). The findings of the study will be published in a peer-reviewed journal and disseminated at national and international conferences and through social media. Trial registration number The protocol for this study was registered with the International Clinical Trials Registry ( ISRCTN15749766 ) https://doi.org/10.1186/ISRCTN15749766 ).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.069
metaresearch head score (Gemma)0.060
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.072
Threshold uncertainty score0.363

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0690.060
Meta-epidemiology (narrow)0.0070.004
Meta-epidemiology (broad)0.0110.007
Bibliometrics0.0030.004
Science and technology studies0.0030.005
Scholarly communication0.0050.005
Open science0.0050.003
Research integrity0.0080.008
Insufficient payload (model declined to judge)0.0720.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.052
GPT teacher head0.420
Teacher spread0.368 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueBMJ Open→Same topicBRCA gene mutations in cancer→French-language works237,207→